|
Age (in years)*
|
85.76 (7.02)
|
83.31 (6.88)
|
84.13 (7.01)
|
|
Baseline QoLb (EQ-5D 3 L score)*
|
0.41 (0.31)
|
0.49 (0.29)
|
0.46 (0.30)
|
|
Baseline functional status (Barthel Index)
|
57.46 (21.4)
|
60.99 (20.70)
|
59.81 (20.95)
|
|
Baseline cognitive function SMMSEc score)
|
22.24 (5.54)
|
23.63 (4.97)
|
23.17 (5.22)
|
|
Baseline depressive symptoms (GDS-15d score)*
|
5.84 (2.97)
|
4.30 (2.97)
|
4.80 (3.05)
|
|
Body mass index (BMI)e
|
24.03 (5.79)
|
24.47 (5.86)
|
24.32 (5.83)
|
| |
n (%)
|
n (%)
|
n (%)
|
|
Gender (female)
|
44 (58)
|
94 (62)
|
138 (61)
|
|
Individuals with a QoLf gain over 12 months
|
28 (42)
|
67 (48)
|
95 (46)
|
|
Individuals dead at 12 months
|
18 (24)
|
35 (23)
|
53 (23)
|
|
Place of death
|
|
Hospital
|
10 (56)
|
21 (60)
|
31 (58)
|
|
Residential Care/Respite
|
8 (44)
|
11 (31)
|
19 (36)
|
|
Home/Independent
|
0 (0)
|
3 (9)
|
3 (6)
|
|
Living unit
|
|
Type of ADa completed (%)
|
|
GPCPg
|
35 (46)
| | |
|
EPGh
|
21 (28)
| | |
|
MDi
|
20 (26)
| | |
|
When AD was completedj
|
|
Before admission to TCk
|
22 (30)
| | |
|
During admission to TCk
|
51 (70)
| | |
|
Trial Arm
|
|
Intervention*
|
53 (70)
|
63 (41)
|
116 (51)
|
|
Usual care*
|
23 (30)
|
89 (59)
|
112 (49)
|
